Cannabinoid treatment for autism: a proof-of-concept randomized trial.
Aran A, Harel M, Cassuto H, Polyansky L, Schnapp A, Wattad N, Shmueli D, Golan D, Castellanos FX.
Aran A, et al.
Mol Autism. 2021 Feb 3;12(1):6. doi: 10.1186/s13229-021-00420-2.
Mol Autism. 2021.
PMID: 33536055
Free PMC article.
Clinical Trial.
BACKGROUND: Endocannabinoid dysfunction in animal models of autism spectrum disorder (ASD) and accumulating, albeit anecdotal, evidence for efficacy in humans motivated this placebo-controlled double-blind comparison of two oral cannabinoid solutions in 150 participants (age 5-21 …
BACKGROUND: Endocannabinoid dysfunction in animal models of autism spectrum disorder (ASD) and accumulating, albeit anecdotal, evidence for …